newsfilter
← Latest News
GlobeNewswire·

Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer

BOSTON, March 10, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ:AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced the appointment o